Verano Holdings (VRNO) Cash & Equivalents (2021 - 2026)
Verano Holdings (VRNO) reported Cash & Equivalents of $74.0 million for Q1 2026, down 12.1% year-over-year from $84.2 million in Q1 2025, and down 10.51% quarter-over-quarter from $82.7 million in Q4 2025.
Verano Holdings (VRNO) Cash & Equivalents (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Cash & Equivalents data on file, last reported at $74.0 million in Q1 2026.
- Cash & Equivalents for Q1 2026 came in at $74.0 million, down 12.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $74.0 million (down 12.1% YoY), and the FY2025 annual result was $82.7 million, down 5.78% from the prior year.
- Cash & Equivalents slipped to $74.0 million in Q1 2026 per VRNO's latest filing, from $82.7 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $193.8 million in Q1 2024 and troughed at $65.0 million in Q3 2024.
- A 5-year average of $101.6 million and a median of $86.3 million in 2022 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2023 and 2025: Cash & Equivalents soared 105.96% in 2023, then plunged 56.54% in 2025.
- A 5-year view of Cash & Equivalents shows it stood at $84.9 million in 2022, then soared by 105.96% to $174.8 million in 2023, then tumbled by 49.76% to $87.8 million in 2024, then slipped by 5.78% to $82.7 million in 2025, then fell by 10.51% to $74.0 million in 2026.
- Business Quant data shows VRNO's Cash & Equivalents at $74.0 million in Q1 2026, $82.7 million in Q4 2025, and $82.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.28 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 40.42 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 266.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 351.55 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 222.27 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 498.58 Mn |
| 10 | Verano Holdings | - | - | 98.98 Mn | 74.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74.03 Mn |
| Dec 31, 2025 | 82.72 Mn |
| Sep 30, 2025 | 82.62 Mn |
| Jun 30, 2025 | 68.57 Mn |
| Mar 31, 2025 | 84.22 Mn |
| Dec 31, 2024 | 87.80 Mn |
| Sep 30, 2024 | 64.98 Mn |
| Jun 30, 2024 | 130.05 Mn |
| Mar 31, 2024 | 193.80 Mn |
| Dec 31, 2023 | 174.76 Mn |
| Sep 30, 2023 | 129.92 Mn |
| Jun 30, 2023 | 102.58 Mn |
| Mar 31, 2023 | 95.13 Mn |
| Dec 31, 2022 | 84.85 Mn |
| Sep 30, 2022 | 76.42 Mn |
| Jun 30, 2022 | 92.83 Mn |
| Dec 31, 2021 | 99.12 Mn |